Showing results (1641-1650 of 2,053) with videos related to
Sort By:
Pageof 206
International Journal of Surgical Investigation|May 9, 2001
Novel methods to evaluate controlled reperfusion techniques in cardiac surgeryJ L Skinner, S B Digerness, R D Spruell, et al.American Journal of Respiratory and Critical Care Medicine|August 14, 2001
Amplification of inflammation in emphysema and its association with latent adenoviral infectionI Retamales, W M Elliott, B Meshi, et al.RSC Chemical Biology|June 28, 2021
In vivo modulation of ubiquitin chains by N-methylated non-proteinogenic cyclic peptidesJoseph M Rogers, Mickal Nawatha, Betsegaw Lemma, et al.Clinical and Experimental Immunology|September 1, 1989
Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosisJ L Macpherson, A Kemp, M Rogers, et al.RSC Chemical Biology|August 30, 2021
Correction: In vivo modulation of ubiquitin chains by N-methylated non-proteinogenic cyclic peptidesJoseph M Rogers, Mickal Nawatha, Betsegaw Lemma, et al.American Journal of Physiology. Heart and Circulatory Physiology|July 30, 2021
Childhood psychosocial stress is linked with impaired vascular endothelial function, lower SIRT1, and oxidative stress in young adulthoodNathaniel D M Jenkins, Emily M Rogers, Nile F Banks, et al.RMD Open|August 10, 2023
Disease-modifying interactions between chronic kidney disease and osteoarthritis: a new comorbid mouse modelSohel M Julovi, Aiken Dao, Katie Trinh, et al.Journal of Vascular Surgery|October 1, 1987
A metropolitan experience with infrainguinal revascularization. Operative risk and late results in northeastern OhioT D Rafferty, J C Avellone, C J Farrell, et al.Antimicrobial Agents and Chemotherapy|May 19, 2000
Use of drug effect interaction modeling with Monte Carlo simulation to examine the impact of dosing interval on the projected antiviral activity of the combination of abacavir and amprenavirG L Drusano, D Z D'Argenio, S L Preston, et al.The Prostate|July 1, 1999
Follow-up evaluation of a phase II prostate cancer vaccine trialB A Tjoa, S J Simmons, A Elgamal, et al.Pageof 206